Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Director bought 626 shares at an average $2.43 ($1,524)
  2. 4 Open-market buy Director bought 976 shares at an average $2.44 ($2,377)
  3. 4 Open-market buy Director bought 1,990 shares at an average $2.44 ($4,851)
  4. 4 Open-market buy Director bought 3,280 shares at an average $2.44 ($7,996)
  5. 4 Open-market buy Director bought 678 shares at an average $2.31 ($1,569)
  6. 4 Open-market buy Director bought 1,057 shares at an average $2.31 ($2,446)
  7. 4 Open-market buy Director bought 2,125 shares at an average $2.31 ($4,912)
  8. 4 Open-market buy Director bought 3,566 shares at an average $2.31 ($8,241)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 4 Other disposition SVP and Chief Development Off. disposed of 33,500 shares (other)
  14. 4 Open-market buy Director bought 533 shares at an average $2.04 ($1,088)
  15. 4 Open-market buy Director bought 797 shares at an average $2.04 ($1,628)
  16. 4 Open-market buy Director bought 2,717 shares at an average $2.04 ($5,548)
  17. 4 Open-market buy Director bought 1,623 shares at an average $2.04 ($3,314)
  18. 4 Open-market buy Director bought 480 shares at an average $2.30 ($1,103)
  19. 4 Open-market buy Director bought 718 shares at an average $2.30 ($1,650)
  20. 4 Open-market buy Director bought 1,441 shares at an average $2.30 ($3,311)

Page 14 of 52 · 1,039 filings